Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Del Dotto

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Archives of Neurology|November 11, 1999
Amantadine for levodopa-induced dyskinesias: a 1-year follow-up studyL V Metman, P Del Dotto, K LePoole, et al.
Neurology|July 23, 1998
Dextromethorphan improves levodopa-induced dyskinesias in Parkinson's diseaseL Verhagen Metman, P Del Dotto, R Natté, et al.
Clinical Neuropharmacology|February 27, 1999
Pharmacokinetics and pharmacodynamics of L-Dopa after acute and 6-week tolcapone administration in patients with Parkinson's diseaseA Napolitano, P Del Dotto, L Petrozzi, et al.
Journal of Neural Transmission. Supplementum|January 1, 1995
Cabergoline improves motor disability without modifying L-dopa plasma levels in fluctuating Parkinson's disease patientsP Del Dotto, A Colzi, C Pardini, et al.
Clinical Neuropharmacology|October 23, 1997
Clinical and pharmacokinetic evaluation of L-dopa and cabergoline cotreatment in Parkinson's diseaseP Del Dotto, A Colzi, E Musatti, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 7, 2001
Proton magnetic resonance spectroscopy (1H-MRS) of motor cortex and basal ganglia in de novo Parkinson's disease patientsC Lucetti, P Del Dotto, G Gambaccini, et al.
Amino Acids|January 1, 1999
Blockade of glutamatergic transmission as treatment for dyskinesias and motor fluctuations in Parkinson's diseaseL Verhagen Metman, P Del Dotto, P J Blanchet, et al.
Clinical Neuropharmacology|February 22, 2000
Diurnal motor variations to repeated doses of levodopa in Parkinson's diseaseU Bonuccelli, P Del Dotto, C Lucetti, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 8, 2001
Intravenous amantadine improves levadopa-induced dyskinesias: an acute double-blind placebo-controlled studyP Del Dotto, N Pavese, G Gambaccini, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 7, 2001
Cytogenetic analysis oxidative damage in lymphocytes of Parkinson's disease patientsL Petrozzi, C Lucetti, G Gambaccini, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Archives of Neurology|November 11, 1999
Amantadine for levodopa-induced dyskinesias: a 1-year follow-up studyL V Metman, P Del Dotto, K LePoole, et al.
Neurology|July 23, 1998
Dextromethorphan improves levodopa-induced dyskinesias in Parkinson's diseaseL Verhagen Metman, P Del Dotto, R Natté, et al.
Clinical Neuropharmacology|February 27, 1999
Pharmacokinetics and pharmacodynamics of L-Dopa after acute and 6-week tolcapone administration in patients with Parkinson's diseaseA Napolitano, P Del Dotto, L Petrozzi, et al.
Journal of Neural Transmission. Supplementum|January 1, 1995
Cabergoline improves motor disability without modifying L-dopa plasma levels in fluctuating Parkinson's disease patientsP Del Dotto, A Colzi, C Pardini, et al.
Clinical Neuropharmacology|October 23, 1997
Clinical and pharmacokinetic evaluation of L-dopa and cabergoline cotreatment in Parkinson's diseaseP Del Dotto, A Colzi, E Musatti, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 7, 2001
Proton magnetic resonance spectroscopy (1H-MRS) of motor cortex and basal ganglia in de novo Parkinson's disease patientsC Lucetti, P Del Dotto, G Gambaccini, et al.
Amino Acids|January 1, 1999
Blockade of glutamatergic transmission as treatment for dyskinesias and motor fluctuations in Parkinson's diseaseL Verhagen Metman, P Del Dotto, P J Blanchet, et al.
Clinical Neuropharmacology|February 22, 2000
Diurnal motor variations to repeated doses of levodopa in Parkinson's diseaseU Bonuccelli, P Del Dotto, C Lucetti, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 8, 2001
Intravenous amantadine improves levadopa-induced dyskinesias: an acute double-blind placebo-controlled studyP Del Dotto, N Pavese, G Gambaccini, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 7, 2001
Cytogenetic analysis oxidative damage in lymphocytes of Parkinson's disease patientsL Petrozzi, C Lucetti, G Gambaccini, et al.
Pageof 3